STRUCTURAL REQUIREMENTS FOR TISSUE FACTOR PATHWAY INHIBITOR INTERACTIONS WITH FACTOR XA AND HEPARIN

被引:97
作者
WESSELSCHMIDT, R
LIKERT, K
HUANG, Z
MACPHAIL, L
BROZE, GJ
机构
[1] Division of Hematology/Oncology, Jewish Hospital, Washington University Medical Center, St. Louis, MO 63110
关键词
TISSUE FACTOR PATHWAY INHIBITOR (TFPI); FACTOR XA; HEPARIN;
D O I
10.1097/00001721-199304050-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor pathway inhibitor (TFPI) is a multivalent Kunitz-type protease inhibitor, which inhibits factor Xa directly and in a factor Xa dependent manner inhibits the factor VIIa/tissue factor catalytic complex. Altered forms of recombinant TFPI (rTFPI) were tested for their ability to inhibit human factor Xa and bovine gamma-carboxyglutamate (Gla)-domainless factor Xa in the presence and absence of calcium ions, heparin, phospholipids, and factor Va. Sequential deletions of the positively charged C-terminus of TFPI produces proteins that have decreasing inhibitory activity against factor Xa as well as decreasing affinity for heparin-agarose. Deletion of the C-terminus distal to Leu181, which eliminates the third Kunitz-type domain, results in the loss of heparin-agarose binding at physiological ionic strength. Furthermore, the entire C-terminal polypeptide, including at least a portion of the third Kunitz-type domain, appears to be involved in heparin binding. Residues 230-241 probably form an alpha helix in which Lys231 and Arg237 within the Kunitz domain and Lys240 and Lys241 could provide a positively charged surface epitope capable of binding heparin. Heparin and Ca2+ together, but not individually, enhance the rate of factor Xa inhibition by full-length TFPI. The effect of heparin is concentration dependent and biphasic (maximal between 0.1 and 1.0 unit/ml) suggesting that the acceleration of factor Xa inhibition occurs at least in part through a 'template' mechanism. Full-length rTFPI inhibits factor Xa in the presence of Ca2+, phospholipids and factor Va more effectively than factor Xa in the presence of Ca2+ alone and is a more potent inhibitor of factor Xa under the former conditions than carboxy-terminal truncated forms of rTFPI. Additional studies show that the acidic N-terminus of TFPI is not required for Xa inhibition and suggest that in a non-physiological system lacking Ca2. the cluster of basic amino acids near the C-terminus of TFPI may interact with factor Xa in a Gla domain dependent fashion.
引用
收藏
页码:661 / 669
页数:9
相关论文
共 29 条
[1]  
BROZE GJ, 1980, J BIOL CHEM, V255, P1242
[2]  
BROZE GJ, 1988, BLOOD, V71, P335
[3]   REGULATION OF COAGULATION BY A MULTIVALENT KUNITZ-TYPE INHIBITOR [J].
BROZE, GJ ;
GIRARD, TJ ;
NOVOTNY, WF .
BIOCHEMISTRY, 1990, 29 (33) :7539-7546
[4]   THE STRUCTURE OF HEPARIN OLIGOSACCHARIDE FRAGMENTS WITH HIGH ANTI-(FACTOR-XA) ACTIVITY CONTAINING THE MINIMAL ANTITHROMBIN-III-BINDING SEQUENCE - CHEMICAL AND C-13 NMR-STUDIES [J].
CASU, B ;
ORESTE, P ;
TORRI, G ;
ZOPPETTI, G ;
CHOAY, J ;
LORMEAU, JC ;
PETITOU, M ;
SINAY, P .
BIOCHEMICAL JOURNAL, 1981, 197 (03) :599-609
[5]   STRUCTURE-ACTIVITY RELATIONSHIP IN HEPARIN - A SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR ANTI-THROMBIN-III AND ELICITING HIGH ANTI-FACTOR-XA ACTIVITY [J].
CHOAY, J ;
PETITOU, M ;
LORMEAU, JC ;
SINAY, P ;
CASU, B ;
GATTI, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (02) :492-499
[6]  
DANIELSSON A, 1986, J BIOL CHEM, V261, P5467
[7]  
DEISENHOFER J, 1974, PROTEINASE INHIBITOR, P484
[8]   INHIBITION OF PROTHROMBINASE COMPLEX BY PLASMA PROTEINASE-INHIBITORS [J].
ELLIS, V ;
SCULLY, MF ;
KAKKAR, VV .
BIOCHEMISTRY, 1984, 23 (24) :5882-5887
[9]  
ESMON CT, 1974, THESIS WASHINGTON U
[10]   IDENTIFICATION OF THE 1.4 KB AND 4.0 KB MESSAGES FOR THE LIPOPROTEIN ASSOCIATED COAGULATION INHIBITOR AND EXPRESSION OF THE ENCODED PROTEIN [J].
GIRARD, TJ ;
WARREN, LA ;
NOVOTNY, WF ;
BEJCEK, BE ;
MILETICH, JP ;
BROZE, GJ .
THROMBOSIS RESEARCH, 1989, 55 (01) :37-50